These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 28588262

  • 21. Design, synthesis, and biological evaluation of benzo[b]thiophene 1,1-dioxide derivatives as potent STAT3 inhibitors.
    Li WZ, Xi HZ, Wang YJ, Ma HB, Cheng ZQ, Yang Y, Wu ML, Liu TM, Yang W, Wang Q, Liao MY, Xia Y, Zhang YW.
    Chem Biol Drug Des; 2021 Nov; 98(5):835-849. PubMed ID: 34416096
    [Abstract] [Full Text] [Related]

  • 22. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
    Yu W, Xiao H, Lin J, Li C.
    J Med Chem; 2013 Jun 13; 56(11):4402-12. PubMed ID: 23651330
    [Abstract] [Full Text] [Related]

  • 23. Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3.
    Fan D, Liu P, Li Z, He X, Zhang L, Jiang W, Ang W, Yang T.
    Bioorg Chem; 2024 Sep 13; 150():107565. PubMed ID: 38905884
    [Abstract] [Full Text] [Related]

  • 24. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
    Shi ZB, Zhao D, Huang YY, Du Y, Cao XR, Gong ZN, Zhao R, Li JX.
    Chem Pharm Bull (Tokyo); 2012 Sep 13; 60(12):1574-80. PubMed ID: 23207637
    [Abstract] [Full Text] [Related]

  • 25. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.
    Bhasin D, Etter JP, Chettiar SN, Mok M, Li PK.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6864-7. PubMed ID: 24176397
    [Abstract] [Full Text] [Related]

  • 26. Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.
    Fan C, Lou S, Shen C, Liao J, Ni H, Chen S, Zhu Z, Hu X, Xie W, Zhao H, Cui S.
    J Med Chem; 2024 Sep 12; 67(17):15291-15310. PubMed ID: 39226127
    [Abstract] [Full Text] [Related]

  • 27. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.
    Park IH, Li C.
    J Mol Recognit; 2011 Sep 12; 24(2):254-65. PubMed ID: 21360612
    [Abstract] [Full Text] [Related]

  • 28. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
    Zhou Q, Peng C, Du F, Zhou L, Shi Y, Du Y, Liu D, Sun W, Zhang M, Chen G.
    Eur J Med Chem; 2018 May 10; 151():39-50. PubMed ID: 29604543
    [Abstract] [Full Text] [Related]

  • 29. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
    Huang W, Liu Y, Wang J, Yuan X, Jin HW, Zhang LR, Zhang JT, Liu ZM, Cui JR.
    Eur J Med Chem; 2018 Sep 05; 157():887-897. PubMed ID: 30145375
    [Abstract] [Full Text] [Related]

  • 30. Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization.
    Qiu HY, Wang F, Wang X, Sun WX, Qi JL, Pang YJ, Yang RW, Lu GH, Wang XM, Yang YH.
    ChemMedChem; 2017 Mar 07; 12(5):399-406. PubMed ID: 28211616
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
    Huang G, Zhao HR, Meng QQ, Zhang QJ, Dong JY, Zhu BQ, Li SS.
    Eur J Med Chem; 2018 Jan 01; 143():166-181. PubMed ID: 29174813
    [Abstract] [Full Text] [Related]

  • 32. A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.
    Zhao W, Jaganathan S, Turkson J.
    J Biol Chem; 2010 Nov 12; 285(46):35855-65. PubMed ID: 20807764
    [Abstract] [Full Text] [Related]

  • 33. N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin.
    Zhou Q, Zhu J, Chen J, Ji P, Qiao C.
    Bioorg Med Chem; 2018 Jan 01; 26(1):96-106. PubMed ID: 29174507
    [Abstract] [Full Text] [Related]

  • 34. Isocryptotanshinone, a STAT3 inhibitor, induces apoptosis and pro-death autophagy in A549 lung cancer cells.
    Guo S, Luo W, Liu L, Pang X, Zhu H, Liu A, Lu J, Ma DL, Leung CH, Wang Y, Chen X.
    J Drug Target; 2016 Dec 01; 24(10):934-942. PubMed ID: 26904961
    [Abstract] [Full Text] [Related]

  • 35. Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
    Huang M, Chen Z, Zhang L, Huang Z, Chen Y, Xu J, Zhang J, Shu X.
    Bioorg Med Chem Lett; 2016 Nov 01; 26(21):5172-5176. PubMed ID: 27727126
    [Abstract] [Full Text] [Related]

  • 36. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.
    Li S, Zhang W, Yang Y, Ma T, Guo J, Wang S, Yu W, Kong L.
    Eur J Med Chem; 2016 Nov 29; 124():1006-1018. PubMed ID: 27783972
    [Abstract] [Full Text] [Related]

  • 37. Chemical probes that competitively and selectively inhibit Stat3 activation.
    Xu X, Kasembeli MM, Jiang X, Tweardy BJ, Tweardy DJ.
    PLoS One; 2009 Nov 29; 4(3):e4783. PubMed ID: 19274102
    [Abstract] [Full Text] [Related]

  • 38. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J, Liu WQ, Sancier F, Edmonds T, Pamonsinlapatham P, Cruzalegui F, Garbay C.
    Biochimie; 2009 Aug 29; 91(8):996-1002. PubMed ID: 19470402
    [Abstract] [Full Text] [Related]

  • 39. Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.
    Pallandre JR, Borg C, Rognan D, Boibessot T, Luzet V, Yesylevskyy S, Ramseyer C, Pudlo M.
    Eur J Med Chem; 2015 Oct 20; 103():163-74. PubMed ID: 26352675
    [Abstract] [Full Text] [Related]

  • 40. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells.
    Seo HS, Ku JM, Choi HS, Choi YK, Woo JK, Kim M, Kim I, Na CH, Hur H, Jang BH, Shin YC, Ko SG.
    Oncol Rep; 2016 Jul 20; 36(1):31-42. PubMed ID: 27175602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.